Evidence for early disease-modifying drugs in rheumatoid arthritis

Some research evidence supports early aggressive treatment of rheumatoid arthritis (RA) using combination therapy with two or more disease modifying anti-rheumatic drugs (DMARDs) plus steroids, or even DMARDs plus an anti-TNF. By contrast, conservatively delayed DMARD monotherapy, given after non-st...

Descripción completa

Detalles Bibliográficos
Autor principal: Scott, David L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400421/
https://www.ncbi.nlm.nih.gov/pubmed/14979927
http://dx.doi.org/10.1186/ar1030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400421/
https://www.ncbi.nlm.nih.gov/pubmed/14979927
http://dx.doi.org/10.1186/ar1030

Ejemplares similares